OAM
VIVE

Oxford Asset Management’s VIVEVE MED INC VIVE Stock Holding History

Oxford Asset Management’s Portfolio VIVE Stock Details VIVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-62
Closed -$65K – 2093
2018
Q4 		$65K Buy
+62
New +$149K ﹤0.01% 1684

Other funds holding VIVE

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

Oxford Asset Management's VIVE Position: Q1 2019 in Review

Oxford Asset Management sold out of VIVEVE MED INC (VIVE) in Q1 2019, closing a stake of 62 shares — an estimated $65K sold.

Oxford Asset Management first reported a position in VIVE in Q4 2018 and held it in 1 quarter. The position peaked at $65K in Q4 2018. 30 funds tracked by Wall St. Rank hold VIVE as of Q1 2019.

  • Oxford Asset Management reported no remaining VIVEVE MED INC position as of Q1 2019 after selling out during the quarter.
  • Oxford Asset Management sold 62 VIVEVE MED INC shares in Q1 2019, an estimated $65K.
  • Oxford Asset Management first reported a position in VIVEVE MED INC in Q4 2018 and held it in 1 quarter.
  • Oxford Asset Management's VIVEVE MED INC position peaked at $65K in Q4 2018.
  • 30 funds tracked by Wall St. Rank held VIVEVE MED INC as of Q1 2019.

Based on Oxford Asset Management's 13F filing for Q1 2019, filed 15 May 2019.